scispace - formally typeset
Y

Yoann Nedelec

Researcher at World Health Organization

Publications -  7
Citations -  376

Yoann Nedelec is an academic researcher from World Health Organization. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 4, co-authored 5 publications receiving 208 citations.

Papers
More filters
Journal ArticleDOI

Progress Toward Regional Measles Elimination - Worldwide, 2000-2018

TL;DR: Progress toward WHA milestones and regional measles elimination during 2000-2018 is described and resource commitments are needed to strengthen routine immunization systems, close historical immunity gaps, and improve surveillance.
Journal ArticleDOI

Global Routine Vaccination Coverage, 2018.

TL;DR: To reach global vaccination coverage goals for vaccines recommended during childhood, adolescence, and adulthood, tailored strategies that address local determinants for incomplete vaccination are needed, including targeting hard-to-reach and hard- to-vaccinate populations.
Journal ArticleDOI

Progress Toward Regional Measles Elimination - Worldwide, 2000-2020.

TL;DR: In this paper, the authors describe progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and update a previous report, and highlight robust measles surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children.
Journal ArticleDOI

The Changing Global Epidemiology of Measles, 2013-2018.

TL;DR: Although most measles case patients are <15 years of age, an age shift is seen in countries with a higher income or a stronger historical vaccination program, which means countries must strengthen immunization programs to achieve high vaccination coverage.
Journal ArticleDOI

The epidemiology of rubella, 2007-18: an ecological analysis of surveillance data.

TL;DR: Vaccination has been successful in decreasing the burden of rubella, regardless of the strategy used, and countries should introduce the rubella-containing vaccine as soon as possible to eliminate rubella and to prevent the morbidity and mortality associated with CRS.